Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Viviana Barbieri"'
Autor:
Valentina Ciappolino, Paolo Brambilla, Alessandro Pigoni, Gian Mario Mandolini, Lucio Oldani, Claudia Cinnante, Viviana Barbieri, Matteo Lazzaretti, Giuseppe Delvecchio, Elisabetta Caletti, Fabio Triulzi, Giandomenico Schiena
Publikováno v:
Journal of visualized experiments : JoVE. (162)
Cannabis is the illicit drug most commonly used worldwide, and its consumption can both induce psychiatric symptoms in otherwise healthy subjects and unmask a florid psychotic picture in patients with a prior psychotic risk. Previous studies suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f76cdfd697f06e4cdd98569e8939d93
https://pubmed.ncbi.nlm.nih.gov/32894263
https://pubmed.ncbi.nlm.nih.gov/32894263
Autor:
Vincenzo Fusco, Giampiero Ausili Cefaro, Pietro Sanpaolo, Viviana Barbieri, Domenico Genovesi, Riccardo A. Audisio
Publikováno v:
Journal of Geriatric Oncology. 3:312-319
Objective The aim of this study is to evaluate the survival and tumor characteristics, including breast cancer phenotypes, of older patients affected by breast cancer and compare these results with those of younger patients. Materials and Methods Dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0261bf59ffc90045245d43686a35b5f7
https://doi.org/10.1016/j.jgo.2012.06.001
https://doi.org/10.1016/j.jgo.2012.06.001
Publikováno v:
The Breast Journal. 17:377-382
To evaluate overall survival (OS), disease-free survival (DFS), and local-recurrence free survival (LRFS) rates in a subgroup of patients affected by breast cancer expressing a particular phenotype (estrogen receptor negative, progesterone receptor n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c32230834e7b52f6e65074df95a458f
https://doi.org/10.1111/j.1524-4741.2011.01100.x
https://doi.org/10.1111/j.1524-4741.2011.01100.x
Publikováno v:
Clinical Breast Cancer. 11:114-120
Background The aim of this study was to evaluate if the interval between breast-conserving surgery and the start of radiotherapy has an effect on local relapse risk. Materials and Methods Between January 2000 and December 2006 a total of 387 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2d524ba4b259de5ce240ff1636b737
https://doi.org/10.1016/j.clbc.2011.03.004
https://doi.org/10.1016/j.clbc.2011.03.004
Publikováno v:
Medical Oncology. 29:459-465
To evaluate overall survival, distant metastases-free survival and local relapse-free survival rates in a subgroup of patients affected by breast cancer expressing Her-2/neu. Data of 195 women affected by very early-stage breast cancer (pT1a-b pN0) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32ef14137e8ee0063d7bf5e533df4cb
https://doi.org/10.1007/s12032-011-9869-0
https://doi.org/10.1007/s12032-011-9869-0
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 190(8)
It is not clear if prolongation of definitive external radiation therapy for prostate cancer has an effect on biochemical failure. The aim of this work was to evaluate whether the biologically effective dose (BED), and in particular the duration of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18189ab86d6c9175fe198e670a875319
https://pubmed.ncbi.nlm.nih.gov/24589919
https://pubmed.ncbi.nlm.nih.gov/24589919
Autor:
Domenico Genovesi, Giampiero Ausili Cefaro, Pietro Sanpaolo, Viviana Barbieri, Vincenzo Fusco
Publikováno v:
Breast cancer research and treatment. 134(1)
To evaluate if biologically effective dose (BED), and in particular the duration of radiation treatment, has an effect on local relapse risk. Between January 2000 and December 2008 a total of 762 patients with T1-2 N0/+ breast cancer was treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0854bf5f40401fc19337aca2c2efd00f
https://pubmed.ncbi.nlm.nih.gov/22203436
https://pubmed.ncbi.nlm.nih.gov/22203436
Autor:
Vincenzo Fusco, Viviana Barbieri, G. Castaldo, Marcello Benassi, G. Califano, Lidia Strigari, Piero Sanpaolo, Alba Fiorentino, Rocchina Caivano, Piernicola Pedicini
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 37(4)
To evaluate a nonstandard RapidArc (RA) modality as alternative to high-dose-rate brachytherapy (HDR- BRT) or IMRT treatments of the vaginal vault in patients with gynecological cancer (GC). Nonstandard (with vaginal applicator) and standard (without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac77f7fea4c99a780f3d349331195bbd
https://pubmed.ncbi.nlm.nih.gov/22382087
https://pubmed.ncbi.nlm.nih.gov/22382087
Publikováno v:
The breast journal. 17(4)
To evaluate overall survival (OS), disease-free survival (DFS), and local-recurrence free survival (LRFS) rates in a subgroup of patients affected by breast cancer expressing a particular phenotype (estrogen receptor negative, progesterone receptor n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c9fb0d9a08ecd82c6c1530cedd4880f
https://pubmed.ncbi.nlm.nih.gov/21615820
https://pubmed.ncbi.nlm.nih.gov/21615820
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 37(10)
To ascertain if breast cancer subtypes had prognostic effect on breast cancer specific survival, distant metastases and local relapse rates in women affected by early stage breast cancer.Data of 774 patients affected by early stage breast cancer and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a33c374755ca97281cb39bd26d1f573
https://pubmed.ncbi.nlm.nih.gov/21824742
https://pubmed.ncbi.nlm.nih.gov/21824742